ARUN SREEKUMAR to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications ARUN SREEKUMAR has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
1.716
-
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016 05 19; 7:11612.
Score: 0.439
-
Genomic Aberrations Drive Clonal Evolution of Neuroendocrine Tumors. Trends Endocrinol Metab. 2016 05; 27(5):242-244.
Score: 0.434
-
The hexosamine biosynthetic pathway alters the cytoskeleton to modulate cell proliferation and migration in aggressive prostate cancer. Cell Commun Signal. 2026 Mar 28; 24(1).
Score: 0.217
-
PARP inhibitor response is enhanced in prostate cancer when XRCC1 expression is reduced. NAR Cancer. 2025 06; 7(2):zcaf015.
Score: 0.204
-
Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer. Nat Commun. 2023 06 09; 14(1):3357.
Score: 0.179
-
High throughput microscopy identifies bisphenol AP, a bisphenol A analog, as a novel AR down-regulator. Oncotarget. 2016 Mar 29; 7(13):16962-74.
Score: 0.109
-
Platelet-Synthesized Testosterone in Men with Prostate Cancer Induces Androgen Receptor Signaling. Neoplasia. 2015 Jun; 17(6):490-6.
Score: 0.103
-
Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer. Nat Metab. 2019 01; 1(1):70-85.
Score: 0.033